Great centralisation of data there thanks Mason. Looks like you can add another disease to Table 5 with the release of this paper last week, The essential role of N6-methyladenosine RNA methylation in complex eye diseases - ScienceDirect. This study appears to have used meclofenamic acid as their FTO inhibitor, looking forward to Zantrene being the inhibitor of choice once word gets out there.
Great centralisation of data there thanks Mason. Looks like you...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |